Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
AbbVie Inc | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Amgen Inc | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
AstraZeneca PLC | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
AstraZeneca PLC ADR | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Biogen Inc | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
BioNTech SE ADR | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Bristol-Myers Squibb Co | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Gilead Sciences Inc | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
GSK PLC | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
GSK PLC ADR | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Johnson & Johnson | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Merck & Co Inc | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Moderna Inc | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Novartis AG ADR | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Novartis AG Registered Shares | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Regeneron Pharmaceuticals Inc | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Roche Holding AG | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Roche Holding AG ADR | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Sanofi SA | Salute | Karen Andersen | Strategist | 02/12/2024 | ||
Terumo Corp | Salute | Yurou Zheng | Equity Analyst | 28/11/2024 |